Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

NCT02512380 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: Docetaxel;oxaliplatin;s1
DRUG: oxaliplatin;s1

Sponsor

Chinese Academy of Medical Sciences